Literature DB >> 12733102

The application of the precautionary principle to the blood system: the Canadian blood system's vCJD donor deferral policy.

Kumanan Wilson1, Michael Wilson, Paul C Hébert, Ian Graham.   

Abstract

The precautionary principle is an influential concept that has been widely used in international treaties and declarations involving the protection of the environment. The principle is now being applied to the development of transfusion policy. In this article, we examine the application of the precautionary principle in the policy process leading to Canada's decision to defer donations from individuals who had traveled to the United Kingdom because of concerns over variant Creutzfeldt-Jakob disease. We found that, although the principle prominently influenced the decision-making process, problems existed with its interpretation. In particular, there was difficulty in balancing the risk prevented by applying a precautionary measure against the risk introduced by the same measure; in this case, the potential for shortages of blood. This dilemma is somewhat unique to the public health sector and will likely recur in future applications of the principle to transfusion policy. Copyright 2003, Elsevier. All rights reserved.

Entities:  

Mesh:

Year:  2003        PMID: 12733102     DOI: 10.1053/tmrv.2003.50007

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  3 in total

1.  A Canadian framework for applying the precautionary principle to public health issues.

Authors:  Erica Weir; Richard Schabas; Kumanan Wilson; Chris Mackie
Journal:  Can J Public Health       Date:  2010 Sep-Oct

2.  Problems with precaution: the transfusion medicine experience.

Authors:  Kumanan Wilson; Katherine M Atkinson; Dean A Fergusson; Adalsteinn Brown; Alan Forster; Malia S Q Murphy; Alan T Tinmouth; Jennifer Keelan
Journal:  J Risk Res       Date:  2017-07-29

3.  Variant Creutzfeldt-Jakob disease and the Canadian blood system after the tainted blood tragedy.

Authors:  Kumanan Wilson; Ian Graham; Maura Ricketts; Christopher Dornan; Andreas Laupacis; Paul Hebert
Journal:  Soc Sci Med       Date:  2006-10-02       Impact factor: 4.634

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.